Method of treating defective glucose metabolism using synthetic

Details Method of treating defective glucose metabolism using synthetic Method of treating defective glucose metabolism using synthetic

1994-11-07

1997-07-29

Kunz, Gary L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 172, 514 25, 514 62, 514866, A61K 3170, C07H 15207

Patent

active

056522215

ABSTRACT:
A synthetic insulin mimetic compound is disclosed. Small synthetic amines of disaccharides, such as 2-deoxy-2-amino-galactopyranosyl pinitol are shown to mimic the action of insulin and to modulate its action.

REFERENCES:
patent: 4446064 (1984-05-01), Larner et al.
patent: 4839466 (1989-06-01), Saltiel
patent: 4906468 (1990-03-01), Saltiel
patent: 5124360 (1992-06-01), Larner et al.
Ellestad et al. J. Antibiotics 1982, 35(10), 1418-1421.
Mohlenkamp et al. Aminoglycoside Antibiotics 1968, 33(8), 3163-3165.
Larner et al. Biochem. Biophys. Res. Commun. 1988, 151(3), 1416-1426.
Machicao et al. Biochem. J. 1990, 266, 909-916.
Berlin et al. Tetrahedron 1991, 47(1), 1-20.
Berlin et al., Synthesis of Hexosamine-Inositol-Phosphates Related to Putative Insulin Mediators, vol. 47, No. 1, pp. 1-20, 1991.
Berlin et al, Synthesis of 2-Amino-2-Deoxy-D-Galactosyl-a-1, 3-D-Chiro-Inositol, Tetrahedron Ltrs., vol. 31, No. 8, pp. 1109-1112, 1990.
Plourde et al., Synthesis of a Potentially Insulin-Mimetic Phosphodisaccharide, Tetrahedron Ltrs., vol. 31, No. 19, pp. 2693-2696, 1990.
Plourde et al., Synthesis and Characterization of an Insulin-Mimetic Disaccharide, J. Org. Chem., vol. 57, No. 9, pp. 2606-2610, 1992.
Larner et al., Generation by Insulin of a Chemical Mediator that Controls Protein Phosphorylation/Dephosphorylation, Science, vol. 206, pp. 1408-1410, 1979.
Saltiel et al., In Search of a Second Messenger for Insulin, Invited Review, pp. C1-C11, 1988 Copyright the American Physiological Society.
Saltiel et al., Functional Consequences of Lipid-Mediated Protein-Membrane Interactions, Biochemical Pharmacology, vol. 42, No. 1, pp. 1-11, 1991.
Saltiel, Transmembrane Signaling in Insulin Action, Insulin Action, pp. 107-116, 1989 Alan R. Liss, Inc.
Saltiel, The Role of Glycosyl-Phosphoinositides in Hormone Action Journal of Bioenergetics and Biomembranes, vol. 23, No. 1, pp. 29-41, 1991.
Saltiel, Second Messengers of Insulin Action, TEM Jan./Feb., pp. 158-163 1990.
Saltiel, Signal Transduction in Insulin Action, J. Nutr. Biochem, vol. 1, pp. 180-189, Apr. 1990.
Falck et al., Total Synthesis of the 5-Methylenephosphonate Analogue of d-myo-Inositol 1,4,5-Triphosphate, J. Chem. Soc. Chem. Commun., 953-955, 1990.
Falck et al., Enantiospecific Synthesis of d-myo-Inositol 1,4,5-Trisphosphate from (-) Quinic Acid, Journ. of Organic Chemistry, vol. 54, pp. 5851-5852, 1989.
Falck et al., Total Synthesis of d-myo-Inositol 3,4,5-Trisphosphate and 1,3,4,5-Tetrakisphosphate, Biorg. & Med. Chem Ltrs, vol. 3, No. 4, pp. 717-720, 1993.
Falck et al., Enantiospecific Synthesis of Inositol Polyphosphates, Phosphatidylinositides & Analogues from (-)-Quinic Acid, Reprint ACS Symps, pp. 145-154, 1991.

Affiliated with

Also associated with

Rating

Method of treating defective glucose metabolism using synthetic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating defective glucose metabolism using synthetic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating defective glucose metabolism using synthetic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-633759